Toll Brothers Announces Preserve at San Tan Model Grand Opening in San Tan Valley, Arizona
Globenewswire· 2025-10-03 14:18
Grand opening event on Saturday, Oct. 4 will showcase professionally designed Kenly, Eastover, and Lockhart home designsSAN TAN VALLEY, Ariz, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, today announced the opening of its newest model homes at its Preserve at San Tan, a new luxury home community in San Tan Valley, Arizona. A model grand opening event will be held on Saturday, Oct. 4 from 11 a.m. to 4 p.m. at the community located at 35462 N. ...
MAX Power Establishes Saskatchewan Headquarters to Lead Canada’s Natural Hydrogen Breakthrough
Globenewswire· 2025-10-03 14:00
The move to Innovation Saskatchewan facilities in Saskatoon and Regina directly aligns MAX Power with world class research, infrastructure and potential near-term commercial opportunities.Tight alignment with MAX Power’s momentum: The relocation dovetails with recent Natural Hydrogen milestones (key personnel, financings, and the commencement this quarter of Canada’s first-ever dedicated Natural Hydrogen multi-well deep drilling program).The relocation places MAX Power’s leadership at the heart of Canada’s ...
Toll Brothers at Ridge Pointe Estates Now Open in McLendon-Chisholm, Texas
Globenewswire· 2025-10-03 14:00
New luxury home community offers expansive one-acre home sites and a variety of architectural stylesMCLENDON-CHISHOLM, Texas, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Toll Brothers, Inc. (NYSE:TOL), the nation's leading builder of luxury homes, today announced the grand opening of Toll Brothers at Ridge Pointe Estates, a new community luxury home community located in McLendon-Chisholm, Texas. The Sales Center is now open at 109 Sweet Tea Road in McLendon-Chisholm. Toll Brothers at Ridge Pointe Estates features an ...
Q-Gold Closes $11,500,000 Fully Allocated Private Placement Financing, Including Agent’s 15% Over-Allotment Option
Globenewswire· 2025-10-03 13:39
TORONTO, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Q-Gold Resources Ltd. (TSXV: QGR) (“Q-Gold” or the “Company”) is pleased to announce that it has closed its previously announced private placement offering of subscription receipts (each, a “Subscription Receipt”). Pursuant to an agency agreement dated October 3, 2025 (the "Agency Agreement") between the Company and BMO Capital Markets, as agent (the "Agent"), the Company issued a total 76,666,667 Subscription Receipts at a price of $0.15 per Subscription Receipt f ...
Akari Therapeutics Announces Abstract Accepted for Oral Presentation at the 40th Annual Society for Immunotherapy of Cancer (SITC) Meeting
Globenewswire· 2025-10-03 13:30
BOSTON and LONDON, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced its abstract has been accepted for oral presentation at the 40th Annual SITC Meeting being held November 5-9, 2025 in National Harbor, MD. Details of the oral presentation are as follows: Title: A Novel Splicing-Targeted ADC Payload Drives Immune Activation, Synergy with Checkpoint Inhibitors, and Enhanced The ...
Parsons Honored as One of Glassdoor’s Best-Led Companies
Globenewswire· 2025-10-03 13:30
CHANTILLY, Va., Oct. 03, 2025 (GLOBE NEWSWIRE) -- Parsons Corporation announced today that it has been recognized by Glassdoor, an online community for workplace conversations, with a mission to build healthier, more transparent work communities for all, as one of the Best-Led Companies. The recognition is based on employee reviews and ratings published on Glassdoor in the previous year. In 2025, 50 honorees were recognized, representing a myriad of industries from food service to software. At #27, Parsons ...
Youxin Technology Ltd Regains Compliance with Nasdaq Stockholders’ Equity Rule
Globenewswire· 2025-10-03 13:30
GUANGZHOU, CHINA, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Youxin Technology Ltd (Nasdaq: YAAS) (the “Company” or “Youxin Technology”), a software as a service (“SaaS”) and platform as a service (“PaaS”) provider committed to helping retail enterprises digitally transform their businesses, today announced that the Company received a formal notice from the Listings Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) on October 2, 2025, confirming that the Company has regained compliance with Nasdaq ...
Merit Medical Systems to Announce Third Quarter 2025 Results on October 30, 2025
Globenewswire· 2025-10-03 13:25
SOUTH JORDAN, Utah, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer and marketer of healthcare technology, announced today that it will release its financial results for the quarter ended September 30, 2025, after the close of the stock market on Thursday, October 30, 2025. Merit plans to hold its investor conference call on the same day (Thursday, October 30, 2025) at 5:00 p.m. Eastern (4:00 p.m. Central, 3:00 p.m. Mountain, and 2:00 p.m. Pacific) ...
Outcrop Silver Announces Closing of $23 Million Public Offering, Including Full Exercise of the Over-Allotment Option, Led by Investment from Jupiter Asset Management and Eric Sprott
Globenewswire· 2025-10-03 13:14
Not for distribution to U.S. news wire services or dissemination in the United States. VANCOUVER, British Columbia, Oct. 03, 2025 (GLOBE NEWSWIRE) -- Outcrop Silver & Gold Corporation (TSXV:OCG, OTCQX:OCGSF, DE:MRG) (“Outcrop Silver” or the “Company”) is pleased to announce that it has closed its previously announced public offering (the “Offering”) of 65,780,000 units of the Company (the “Units”) at a price of $0.35 per Unit, for aggregate gross proceeds of approximately $23,023,000, including the full exe ...
ALX Oncology to Present Updated Data from Phase 2 ASPEN-06 Trial, Highlighting CD47 Expression as a Predictive Biomarker in HER2+ Gastric Cancer, at 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting
Globenewswire· 2025-10-03 13:05
Company will share data demonstrating CD47 overexpression as key predictive biomarker for response with the Company’s lead candidate, evorpacept, in HER2+ gastric cancer SOUTH SAN FRANCISCO, Calif., Oct. 03, 2025 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients’ lives, today announced updated data from its Phase 2 ASPEN-06 (NCT05002127) ...